Gaps in the Heart Failure Guidelines - sprookjes - yvandenbroek - TriplyDB

Gaps in the Heart Failure Guidelines

Gaps in the Heart Failure Guidelines

http://www.wikidata.org/entity/Q57630227

about

Gaps in the Heart Failure Guidelines

http://www.wikidata.org/entity/Q57630227

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2014

@uk

name

Gaps in the Heart Failure Guidelines

@en

Gaps in the Heart Failure Guidelines

@nl

type

label

Gaps in the Heart Failure Guidelines

@en

Gaps in the Heart Failure Guidelines

@nl

prefLabel

Gaps in the Heart Failure Guidelines

@en

Gaps in the Heart Failure Guidelines

@nl

P1433

Q57630227-5DAFD357-38AE-4BF5-8D35-A644BBE4532E

P1476

Q57630227-19110CFA-E4EB-4C45-A829-CB0C6EEA6C78

P2093

Q57630227-01F6B412-BAF3-4985-A47A-41327878C253

P2860

Q57630227-00CC58C9-CAFB-4C53-A473-C1AA3E31EF9A

Q57630227-043BBD0B-FC9C-4C4C-8961-3C1CB1BBA288

Q57630227-0689D322-A2DC-4CFA-82ED-5C0AB5F24627

Q57630227-0D123483-7160-4EE3-B7E6-61FEF4C7FE76

Q57630227-0D4849BF-F529-4489-9B8D-CABE604DCD84

Q57630227-10C8A71E-8ACD-45FE-A016-346F5B9B72D3

Q57630227-12A73CF3-4E2B-4E49-B27F-F1963621DFCC

Q57630227-14D78F0B-DCBB-465A-8AAC-63F180A79D8C

Q57630227-1D6A79CF-BC4D-4956-8FEF-65C6AE206522

Q57630227-1D868863-AE9C-4AEE-9501-111B9DE3973A

P304

Q57630227-6B193E2B-348B-4187-B6ED-510A21992FF3

P31

Q57630227-AC3D7BDD-86C0-4DFD-864A-FAA82C38046D

P356

Q57630227-9BAACD00-E134-4E18-A1DB-35B0AE2AE6EC

P407

Q57630227-02FF3EB4-83E9-4946-9FCB-86BB66B3188A

P433

Q57630227-8DA427C8-A890-4DA2-A101-E5D08A071565

P478

Q57630227-A21FA5A4-C8B2-4775-8B01-43DBF57C75E9

P50

Q57630227-1CC7A571-B93A-49B9-851D-4F79A9896B09

P577

Q57630227-621AA601-A890-4F77-8309-41583CA3F293

P698

Q57630227-6FCF6C99-2259-44D5-9087-0939423951DD

P932

Q57630227-8A4D0D2C-4B3E-43B4-92D8-95D3F4EB47CF

P356

ECR.2014.9.2.104

P1433

European cardiology

P1476

Gaps in the Heart Failure Guidelines

@en

P2093

Bao Tran

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials

Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System

Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases

Home monitoring for heart failure management

Effect of nesiritide in patients with acute decompensated heart failure

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

P304

104-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15420/ECR.2014.9.2.104

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Gregg C. Fonarow

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30310495

http://www.w3.org/2001/XMLSchema#string

P932

6159402

http://www.w3.org/2001/XMLSchema#string